Fortress Biotech, Inc. Annual report pursuant to Section 13 and 15(d)

Accrued Liabilities and other Long-Term Liabilities

12 Months Ended

Dec. 31, 2013

5. Accrued Liabilities and other Long-Term Liabilities

Accrued expenses and other long-term liabilities consisted of the following:

	As of December 31,
	2013		2012
($ in thousands)
Accrued expenses:
Salaries, bonuses and related benefits	$	450	$	1,064
Severance (Note 15)		1,502		354
Professional fees		351		320
Research and development expenses		1,245		403
State franchise taxes		190
Ovamed manufacturing rights short-term component (Note 14)		500
Other		192		44
Total accrued expenses	$	4,430	$	2,185
Other long-term liabilities:
Hercules Note end of term charge (Note 10)		398		398
Ovamed manufacturing rights long-term component (Note 14)		679		1,043
Total other long-term liabilities	$	1,077	$	1,441